Richard J. Gumina - Concepedia

Author

Richard J. Gumina

Also Known As

Gumina, R.J., Gumina, Richard J., R J Gumina, R. Gumina, R. J. Gumina, R.J. Gumina, RICHARD GUMINA, Richard Gumina, Richard J Gumina, Richard J. Gumina

168

Publications

5.3K

Citations

H-Index

Concepts

All Affiliations

The Ohio State University The Ohio State University Wexner Medical Center The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Mayo Clinic Medical College of Wisconsin

About

Richard J. Gumina is an author at The Ohio State University specializing in medicine, immunology, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	24	1.4K
2	Biochemistry	3	3	278
3	Health Sciences	1	1	14
4	Natural Sciences	1	1	199
5	Public Health	1	1	14

Richard J. Gumina

Publications

4.4K

Citations

H-Index

Page 1

	Year	Citations
Kir6.2 is required for adaptation to stress Leonid V. Zingman, Denice M. Hodgson, Peter Bast, Proceedings of the National Academy of Sciences	2002	308
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2 Panke Qu, John P. Evans, Julia N. Faraone, Cell Host & Microbe Enhanced Neutralization Resistance	2022	276
Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection John P. Evans, Cong Zeng, Claire Carlin, Science Translational Medicine	2022	251
Cloning of the cDNA of a Human Neutrophil Bactericidal Protein Patrick W. Gray, Gail W. Flaggs, Steven R. Leong, Journal of Biological Chemistry BacteriologyImmunologyMolecular BiologyBacteriophageGranule Membrane	1989	199
Enhanced evasion of neutralizing antibody response by Omicron XBB.1.5, CH.1.1, and CA.3.1 variants Panke Qu, Julia N. Faraone, John P. Evans, Cell Reports	2023	183
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2 John P. Evans, Cong Zeng, Panke Qu, Cell Host & Microbe	2022	150
Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants Panke Qu, Kai Xu, Julia N. Faraone, Cell Humoral ResponseViral PathogenesisImmunologyImmune SystemCovid-19	2024	149
Emergency Coronary Artery Bypass Surgery for Percutaneous Coronary Interventions Eric H. Yang, Richard J. Gumina, Ryan J. Lennon, Journal of the American College of Cardiology Cardiac SurgeryPercutaneous Coronary InterventionCardiovascular DiseaseSurgeryPercutaneous Coronary Interventions	2005	141
A New Sodium/Hydrogen Exchange Inhibitor, EMD 85131, Limits Infarct Size in Dogs When Administered Before or After Coronary Artery Occlusion Richard J. Gumina, Tsuneo Mizumura, Norbert Beier, Journal of Pharmacology and Experimental Therapeutics	1998	138
Inhibition of the Na<sup>+</sup>/H<sup>+</sup>Exchanger Confers Greater Cardioprotection Against 90 Minutes of Myocardial Ischemia Than Ischemic Preconditioning in Dogs Richard J. Gumina, Erich Buerger, Christian Eickmeier, Circulation	1999	131

Page 1